So, a mate with insomnia gets a scrip for zolpimist in the far NW of this great country, pays a small fortune, and the only reference in the latest 4C was.....
Not sure that this is industry best practice with regard to ALA's continuous disclosure obligations under the Corporations Act, given it's their only source of income outside of increasingly routine capital raisings and R&D rebates.
zolpimist product
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $126.0M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 13.0¢ | 11.5¢ | $375.7K | 3.063M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 114024 | 2 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
0.005 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 11.8¢ | 13.5¢ | 11.8¢ | 2914423 | ||
| Last updated 15.47pm 26/04/2024 ? | |||||
| ALA (ASX) Chart |